R. Keith Woods has been appointed chief operating officer, argenx. Mr. Woods will be responsible for all aspects of early commercial planning for the company’s lead candidate efgartigimod (ARGX-113), including marketing, market access, program management and supply chain operations. Mr. Woods has more than 25 years of experience in the biopharmaceutical industry. Most recently he served as senior vice president of North American Operations for Alexion Pharmaceuticals Inc., where he mana...